Skip to main content

Table 2 TNM staging based on two staging systems

From: The prognostic value of 11th Japanese classification and 8th AJCC staging systems in Chinese patients with esophageal squamous cell carcinoma

Staging

AJCC 8th staging

JES 11th staging

T staging, n (%)

  

0

2 (0.7%)

0 (0%)

1a

6 (2.2%)

8 (2.9%)

1b

28 (10.4%)

28 (10.4%)

2

47 (17.5%)

47 (17.5%)

3

164 (61.1%)

164 (61.1%)

4

21 (7.8%)

21 (7.8%)

N staging, n (%)

  

0

140 (52.2%)

141 (52.6%)

1

73 (27.2%)

62 (23.1%)

2

36 (13.4%)

58 (21.6%)

3

19 (7.0%)

7 (2.6%)

M staging, n (%)

  

0

267 (99.6%)

268 (100%)

1

1 (0.3%)

0 (0%)

Stage grouping, n (%)

  

0

2 (0.7%)

8 (2.9%)

I

32 (11.9%)

21 (7.8%)

II

106 (39.5%)

119 (44.4%)

III

105 (39.1%)

120 (44.7%)

IV

23 (8.5%)

0 (0%)

  1. AJCC, the American Joint Committee on Cancer; JES, Japan Esophageal Society